NeuroCure – Comprehensive approaches to neurological and psychiatric disorders – from mechanisms to interventions
New perspectives in the therapy of neurological diseases
NeuroCure is a Cluster of Excellence in the neurosciences at the Charité – Universitätsmedizin Berlin funded within the framework of the Excellence Initiative of the German federal and state governments since October 2007. The study of neurological and psychiatric disease mechanisms and the transfer of basic scientific findings to clinical application - in short, translation - are the focus of this interdisciplinary and international consortium.
Together with its partner universities Humboldt-Universität zu Berlin and Freie Universität Berlin, and non-university research institutions including the Max Delbrück Center for Molecular Medicine (MDC) and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), NeuroCure aims to continuously develop and strengthen Berlin as a neuroscience research location. This is being achieved by improving local networks of ongoing research activities, recruiting excellent young scientists and creating new structural modules.
With the goal of transferring insights from basic neuroscience research to clinical studies and developing new therapies and diagnostic approaches, NeuroCure has expanded its scientific focus and spectrum of methods. Investigative approaches range from molecular and imaging methods to behavioral and neuropsychological studies. The focus is on developmental disorders as well as on diseases such as Parkinson’s, multiple sclerosis, Alzheimer’s dementia, and epilepsy, and on various psychiatric disorders such as schizophrenia and depression.
To support Berlin neuroscientists in their research, specialized know-how and state-of-the-art instruments are provided in core facilities. To promote clinical studies, the NeuroCure Clinical Research Center offers expert advice and assistance. In the future, existing structures for strengthening translation will be supplemented by new modules. In close cooperation with the clinical areas of neurosurgery and neurological intensive care, treatment options are being developed, in particular, for acute and hyperacute diseases; the SPARK program will help optimize and accelerate translation processes; and the VOS module will address the predictive power and reproducibility of research.
Coordinator: Prof. Dr. Dietmar Schmitz (Charité – Universitätsmedizin Berlin)
Coordinating institutions: Freie Universität Berlin and Humboldt-Universität zu Berlin are parent universities of the Charité – Universitätsmedizin Berlin.